Document is current

Article History

Received: 26 July 2024

Accepted: 28 November 2024

First Online: 30 January 2025

Declarations

:

: The study was approved by the ethics committee of the Medical Faculty of the University of Würzburg (EC Würzburg 29/20-me) as well as by the ethics committee in Düsseldorf (Study No.2022–2098) and the Charité-Universitätsmedizin Berlin (CTO 23–0983). A written declaration of consent is obtained from all patients (Broad Consent V1.6.f of the Medical Informatics Initiative). We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

: Not applicable.

: PUH reports grants from the German Research Foundation during the work, research grants from the German Ministry of Education and Research, German Research Foundation, European Union, German Parkinson Society, University Hospital Würzburg, Robert Koch Institute, German Heart Foundation, Federal Joint Committee (G-BA) within the Innovationfond, Bavarian State, German Cancer Aid, University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer Ingelheim, and Daiichi Sankyo), Charité–Universitätsmedizin Berlin (within Mondafis; supported by an unrestricted research grant to the Charité from Bayer), and University Göttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer Ingelheim) outside the submitted work. AAK has received research grants from Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research, and Lundbeck Foundation. She has served on advisory boards for Medtronic and Boston Scientific; and has received honoraria for talks sponsored by Medtronic, Boston Scientific, Ipsen, and Teva. She is supported by the Deutsche Forschungsgemeinschaft (project ID 424778381–TRR 295). JV has received research grants from Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research, and ERANET-Neuron. He has served on advisory boards for Medtronic, Boston Scientific, Ceregate, Bayer and Newronika; and has received honoraria for talks sponsored by Medtronic, Boston Scientific, Abbott, AbbVie, Stadapharm. He is supported by the Deutsche Forschungsgemeinschaft (project ID 424778381–TRR 295). PR acknowledges support by the Virtual Research Environment at the Charité Berlin – a node of EBRAINS Health Data Cloud; Digital Europe TEF-Health 101100700, EU H2020 Virtual Brain Cloud 826421, Human Brain Project SGA2 785907; Human Brain Project SGA3 945539, ERC Consolidator 683049; German Research Foundation SFB 1436 (project ID 425899996); SFB 1315 (project ID 327654276); SFB 936 (project ID 178316478; SFB-TRR 295 (project ID 424778381); SPP Computational Connectomics RI 2073/6–1, RI 2073/10–2, RI 2073/9–1; PHRASE Horizon EIC grant 101058240; Berlin Institute of Health & Foundation Charité, Johanna Quandt Excellence Initiative; ERAPerMed Pattern. PK Received speaker´s honoraria from Medtronic, AbbVie and Stadapharm and is in the Advisory Board of Abbot, MedTronic and Stadapharm, outside the submitted work. AS was supported by the Brunhilde Moll Foundation unrelated to this research. He received, unrelated to this research, consulting fees and/or speaker honoraria from Abbott, Abbvie, Alexion, bsh medical communication, GE Healtcare, Kyowa Kirin, Novartis, Zambon, and an editor's fee from Georg Thieme Verlag. CJH received honoraria from Abbott.